Journal profile · NEUROSCIENCES-PERIPHERAL VASCULAR DISEASE
Journal of Stroke & Cerebrovascular Diseases
ISSN 1052-3057 · eISSN 1532-8511 · W.B. Saunders Ltd · UNITED STATES
Journal of Stroke & Cerebrovascular Diseases: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.09; fully open access; APC about USD 2,170; median 83 days to acceptance (102 articles, last 24 months); 315 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Stroke & Cerebrovascular Diseases is published by W.B. Saunders Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases and Stroke Rehabilitation and Recovery, together about 47.8% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, stroke education and curricular innovation reports, controversies, methods and technical notes, selected case reports and other original articles of special nature.Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons, neuro-interventionalists, cardiologists, hospitalists, emergency medicine physicians, and stroke rehabilitation experts.
From the journal's Aims & Scope
Research area (LetPub): NEUROSCIENCES-PERIPHERAL VASCULAR DISEASE
Editor-in-chief Fernando TestaiPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 37, Brazil 5, Argentina 4, United Kingdom 2, Italy 2 (60 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Ischemic Stroke ManagementMedicine25.6%
- Cerebrovascular and Carotid Artery DiseasesMedicine11.4%
- Stroke Rehabilitation and RecoveryMedicine10.8%
- Intracerebral and Subarachnoid Hemorrhage ResearchMedicine8.8%
- Intracranial Aneurysms: Treatment and ComplicationsMedicine6.5%
- Traumatic Brain Injury and Neurovascular DisturbancesMedicine3.3%
- Atrial Fibrillation Management and OutcomesMedicine3%
- Moyamoya disease diagnosis and treatmentMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Neurosciences | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Neurosciences | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Neurosciences | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.09LetPub ·
- Impact factor (publisher)
- 2.1Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- CiteScore (publisher)
- 3.8Publisher website ·
- SJR 2026-06
- 0.69LetPub ·
- SNIP 2026-06
- 0.77LetPub ·
- h-index
- 50LetPub ·
- h-index
- 105OpenAlex ·
- i10-index
- 4,239OpenAlex ·
- 2-year mean citedness
- 3.08OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 36.34%LetPub ·
Volume
- Articles per year
- 289LetPub ·
Articles by year OpenAlex count · 9,855 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 213 | 213 | 62 |
| 2025 | 315 | 315 | 768 |
| 2024 | 577 | 268 | 2,571 |
| 2023 | 478 | 215 | 2,636 |
| 2022 | 555 | 175 | 4,370 |
| 2021 | 615 | 206 | 7,574 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
83 daysMedian, submission to acceptance · P25–P75 66 days – 115 days
- Acceptance to online
- median 1 days (102 articles)
- Submission to online
- median 86 days
- Sample
- 102 articles with submission and acceptance dates (795 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 51 daysPublisher website ·
- Submission to acceptance
- 89 daysPublisher website ·
- Acceptance to publication
- 1 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,170 / EUR 2,030 / GBP 1,740 / JPY 269,150 | — | — | |
| Publisher website | USD 2,170 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted15, with length limits
- case reportTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- commentaryTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- editorialTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- letterTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- letter to the editorTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …main text ≤ 1,500 words
- literature reviewTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- meta-analysisTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- narrative reviewTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- perspectiveTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …main text ≤ 3,000 words
- rapid communicationTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- research reportTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- reviewTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …main text ≤ 3,500 words
- review articleTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- short communicationTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …Length not stated
- systematic reviewTypeDescriptionRequirementsOriginal Study - Clinical Trial- Prospective or Retrospective observational study (cohort studies, case-control study, epidemiologic …main text ≤ 3,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process; submissions assessed by editors and reviewed by a minimum of two reviewers. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 1052-3057
- Electronic ISSN
- 1532-8511
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Stroke & Cerebrovascular Diseases
What CAS zone is Journal of Stroke & Cerebrovascular Diseases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Stroke & Cerebrovascular Diseases is in Zone 4 of Medicine, and in Zone 4 of the minor category Neurosciences / Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Stroke & Cerebrovascular Diseases?
The latest impact factor listed by LetPub is 2.09; CiteScore 3.8, h-index 105.
How long does peer review take at Journal of Stroke & Cerebrovascular Diseases?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 83 days (interquartile range 66–115 days); authors report an average review time of 3–6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Stroke & Cerebrovascular Diseases?
According to the journal's author guidelines: Abstract: ≤ 250 words; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Stroke & Cerebrovascular Diseases based?
Of the 60 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (37), Brazil (5) and Argentina (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Stroke & Cerebrovascular Diseases?
According to LetPub and DOAJ records, Journal of Stroke & Cerebrovascular Diseases is indexed in SCIE, Scopus and DOAJ.
Is Journal of Stroke & Cerebrovascular Diseases open access, and what is the APC?
Journal of Stroke & Cerebrovascular Diseases is a fully open-access journal. APC about USD 2,170.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .